KMICB - Musculoskeletal system
Kent and Medway Guidance
K&M PRGC PR 2024-09: Infliximab without methotrexate for rheumatoid arthritis, May 2024
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary